No Data
On August 7, A-share lightning rod: Guangdong Tecsun Science & Technology - controlling shareholder and actual controller Guo Xiaobin plans to reduce shareholding by no more than 3.00%; Guangdong Highsun Group - Shenzhen Stock Exchange plans to terminate
Guangdong Tecsun Science & Technology's controlling shareholder and actual controller Guo Xiaobin intends to reduce his shareholding by no more than 3.00%; ST Dayoutan announced the termination of the planned change of control and resumed trading from August 7; Guangdong Highsun Group received a notification from the Shenzhen Stock Exchange to terminate the company's stock trading; Jiangyin Hengrun Heavy Industries' shareholder Cheng Lixin's holding of 4.72% of the shares was judicially frozen.
* Special treat Da Yao (603963.SH): Termination of planned change of control, resuming trade from August 7th.
On August 6th, Glory Times reported that ST Dah Yao (603963.SH) received a notice from its controlling shareholder and actual controller Mr. Yang Junxiang on August 6th, 2024. During the trading suspension period, the controlling shareholder and actual controller Mr. Yang Junxiang and the counterparty did not reach a consensus on this transaction. After careful consideration, the controlling shareholder and actual controller Mr. Yang Junxiang decided to terminate the planning of this agreement to transfer the company's shares. After applying to the Shanghai Stock Exchange, the company's stocks will resume trading on August 7, 2024 (Wednesday).
Special treat Da Yao (603963.SH): planning changes in controlling stake, stocks suspended.
On August 5th, Gelunhui reported that *ST Pharma (603963.SH) has received notice that its controlling shareholder and actual controller, Mr. Yang Junxiang, is preparing for the agreement to transfer company shares, which may result in a change of the company's control. The company's stocks will continue to be suspended from August 6th, 2024 (Tuesday), and the total suspension time is expected not to exceed two trading days (including August 5th).
*ST Dapha (603963.SH): As of July 10th, 2024, the company has 16,811 shareholders.
On July 16th, Gelunhui reported that Special Treat Da Yao (603963.SH) stated on the investor interaction platform that the company has not received any relevant notice of changes in shareholding from major shareholders so far. If there are corresponding situations, the company will strictly fulfill its information disclosure obligations in a timely manner according to relevant regulations. As of July 10, 2024, there were 16,811 shareholders of the company.
Announcement of Dali Pharmaceutical Co., Ltd.'s anticipated half-year performance loss for 2024.
ST Daphar (603963.SH) is expected to lose 11-14 million yuan in the first half of the year.
On July 12th, Gelunhui reported that *ST Deyaoyao (603963.SH) announced a pre-loss notice for its 2024 interim performance. According to preliminary calculations by the financial department, the net income attributable to the owner of the parent company for the first half of 2024 is expected to be between -14 million yuan and -11 million yuan, and compared with the same period of the previous year (legally disclosed data), the loss will increase from 3.2176 million yuan to 0.2176 million yuan. It is expected that the net income attributable to the owner of the parent company after deducting non-recurring gains and losses in the first half of 2024 will be -16 million yuan to -13 million yuan.
Capital Allocation Trends At Bomin Electronics (SHSE:603936) Aren't IdealNo Data
